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Abstract Vpu is an 81-residue membrane protein, with a single
transmembrane segment that is encoded by HIV-1 and is in-
volved in the enhancement of virion release via formation of
an ion channel. Cyclohexamethylene amiloride (Hma) has
been shown to inhibit ion channel activity. In the present
12-ns simulation study a putative binding site of Hma blockers
in a pentameric model bundle built of parallel aligned helices of
the ¢rst 32 residues of Vpu was found near Ser-23. Hma ori-
entates along the channel axis with its alkyl ring pointing inside
the pore, which leads to a blockage of the pore.
( 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Vpu is an 81-amino acid protein encoded by HIV-1 with a
high degree of sequence conservation [1]. Its function in the
life cycle of HIV-1 is twofold: (i) to interact with CD4 in the
endoplasmic reticulum to initiate the ubiquinine-mediated
degradation of the CD4^Vpu complex and (ii) to enhance
particle release at the site of the plasma membrane altering
the electrochemical gradient via ion channel formation by
homo-oligomerisation [2] in the lipid membrane. Whilst the
¢rst function is fairly established, the second is still open to
debate [3]. It is still not unambiguously established whether
ion channel activity is an intrinsic property of Vpu. If so, then
a selective blocker needs to be found to give proof, which has
been reported using the derivatives of amiloride (Am) [4].
There are reasonably good structural data available to permit
generation of molecular models of Vpu (for an overview see
[5,6]), in which there is a helical transmembrane (TM) domain
followed by a larger cytoplasmic domain with a helix-loop
helix-helix/turn motif. Such models can be used in molecular
dynamics simulations to investigate the mechanism of func-
tion and also to initiate computational blocker (leading pos-
sibly to drug) screening and development.
This study is based on recent ¢ndings that cyclohexamethy-
lene amiloride (Hma), but not Am itself, blocks channel ac-
tivity of both a peptide corresponding to the TM segment of
Vpu and full-length Vpu when reconstituted into lipid bilayers
[4]. A homo-pentameric bundle based on the ¢rst 32 amino
acids of Vpu in a helical motif was generated. Simulations in
the presence of the blocker aim to shed light on: (i) the site of
action for the blocker with the protein, (ii) whether the block-
er a¡ects the integrity of the bundle, and (iii) the most favour-
able conformation adopted by the blocker. Calculations were
performed with Am as the non-potent blocker for compari-
son. Two di¡erent protonation states for each blocker were
simulated.
2. Materials and methods
2.1. Model building
A pentameric Vpu TM bundle based on the ¢rst 32 amino acids of
Vpu (HV1H2), QPIPIVAIVA10LVVAIIIAIV20VWSIVIIEYR30KI,
was generated with the program X-Plor 3.1 [7] based upon a protocol
described in detail elsewhere [8,9]. This protocol generates symmetri-
cal arrangements of ¢ve K-helices and was based on a simulated an-
nealing procedure with short molecular dynamics (MD) simulations.
The initial inter-helical distance was set to 0.94 nm. During a ¢rst
stage, which involves the simulated annealing, ¢ve structures were
generated based on van der Waals interactions. In the next stage
(stage 2) each of these ¢ve structures was used as a starting point
for the consecutive steps which take electrostatic interactions into
account. At the end 25 structures were obtained. Inter-helical root
mean square deviation (RMSD) values were calculated for each bun-
dle and the bundle with the lowest average RMSD (i.e. the most
symmetrical) was selected.
The structures of Am (3,5-diamino-6-chloro-N-(diaminomethylene)-
pyrazinecarboxamide) and Hma (5-(N,N-hexamethylene) amiloride) in
both a deprotonated (AM, HMA) and a protonated state (proton at
the guanidinium group, AMþ, HMAþ) were generated by applying
DS Viewer Pro 5.0 (Accelerys) and were consequently used in the
AutoDock software [10] to locate the putative binding site of the
blockers with Vpu. In total 10 runs were performed with 30 000 en-
ergy minimisation steps. The conformation of the bundle was kept
rigid, whilst the blocker was allowed to be £exible. All structures
located the energetically most favourable site within the pore close
to the serine residues. From a total of 200 putative docking confor-
mations, the one closest to one of the serines was chosen for MD
simulations. The respective blockers were then placed inside the pore.
The system was then subjected to a 300-ps equilibration keeping only
the position restraints on the backbone of the protein. The topology
of each of the blockers was determined by manually adapting the
output of PRODRG [11] for the force ¢eld GROMOS43a2.
2.2. MD simulations
The in-silico bundle was placed in a lipid bilayer consisting of 96
lipid molecules (1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylcho-
line, POPC) in which a hole, already generated by removing enough
lipids to avoid any overlap with the bundle, was present [12]. The
0014-5793 / 04 / $30.00 K 2004 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(04)00251-0
*Corresponding author. Fax: (44)-1865-275234.
E-mail address: wolfgang.¢scher@bioch.ox.ac.uk (W.B. Fischer).
FEBS 28218 29-3-04
FEBS 28218 FEBS Letters 563 (2004) 75^81
bilayer^bundle system was consequently solvated with 40 water mol-
ecules per lipid to give a system of around 20 000 atoms per experi-
ment. As each helix has a net charge of +1, ¢ve chloride ions (six in
the presence of the protonated blocker) were also added to compen-
sate for any extra charge within the simulation box. The solvated
system was equilibrated for 300 ps with the peptide restrained, fol-
lowed by the production phase of fully unrestrained 12-ns MD sim-
ulation.
For MD simulations GROMACS v3.1.4 software was used. Simu-
lations were run at 300 K in an isothermal^isobaric ensemble (NPT).
Periodic boundaries were present and a Berendsen temperature and
pressure coupling was chosen to keep these parameters constant. The
time step for the simulation was 2 fs. A LINCS algorithm was used to
maintain the geometry of the molecules. Long-range electrostatics
were calculated with the particle-mesh Ewald (PME) method using
standard GROMACS parameters: grid dimensions 0.12 nm, interpo-
lation order 4. Double counting correction for short-range forces was
applied. Lennard^Jones and short-range Coulomb interactions were
cut o¡ at 1.1 and 0.9 nm, respectively. The simple point charge water
model [13] was used to describe the water in the simulation box.
Simulations were performed on a Dell Precision 420 with a dual
Pentium III 1 GHz processor or on a Dell Precision 330 with a
Pentium IV 1.5 GHz. The pore radii were calculated using HOLE2
[14] with radii not being considered if larger than 1.0 nm.
3. Results
The site of Am^Vpu interaction and that of its derivative
Hma with Vpu was elucidated by a docking approach. Inde-
pendent of the number of TM helices the most likely binding
site proposed for both blockers is around Ser-23 (Fig. 1, top
pictures). At the starting structure, the guanidinium group of
each of the blockers points towards the serine residues of the
bundle. At the end of the simulations the blockers remain at
the site of Ser-23. A view down the pore from the C- to the N-
terminus reveals that both Am (Fig. 1A) and Hma (Fig. 1B)
stay in contact with two helices most of the time (Fig. 1,
bottom pictures). Independent of the protonation state, Am
seems to allow more space within the pore for water or ions to
pass through than Hma.
3.1. The protein
The RMSD of the backbone atoms for each of the simu-
lated pentamers, without blocker and in the presence of either
AMþ (Fig. 2A) or HMAþ (Fig. 2B), remains below 0.35 nm
with respect to their initial conformations. The presence of
AM and AMþ does not have any impact on the RMSD. In
both cases the curve can hardly be distinguished from the
bundle without blocker. In the presence of HMA the bundles
show some deviation from the bundle without blocker. Over a
time span of the ¢rst 6 ns the RMSD values for the bundle
with either of the blockers are slightly higher than the bundle
without blocker. After another 6 ns the bundle with the
HMAþ remains approximately 0.05 nm higher than the value
for the bundle without blocker. The RMSD for the bundle
with the HMA approaches the value of the plain bundle.
The averaged root mean square £uctuation (RMSF) per
residue (data not shown) of the bundle is indicative of a larger
deviation of more than 0.3 nm for residues on the C-terminal
end than on the N-terminal end. This is in common for all the
simulations independent of the presence of the blocker and its
protonation state and indicative of a loss of helicity (DSSP
analysis, data not shown) [15]. For the membrane-spanning
amino acids, the £uctuation is below 0.15 nm.
The presence of either of the blockers in the deprotonated
state does not have a major impact on the overall structure of
the bundle. The averaged tilt angle for the bundle without
blocker is about 5.8 P 2.7‡, whilst the values for the bundles
in the presence of the deprotonated blockers do not exceed
11.0P 4.1‡. AMþ and HMAþ induce larger averaged tilt an-
gles of 19.6 P 3.5‡ and 14.9P 7.5‡, respectively. Changes for
the average kink angle and cross angle are small but signi¢-
cant (with a con¢dence interval of 99.99%) indicating that the
blockers do a¡ect the properties of the bundle. The average
inter-helical distances of the helices do not change in the pres-
ence of any of the blockers.
The pore is divided into three areas to re¢ne the analysis of
the e¡ect of the blockers on the pore, the N-terminal (residues
1^11), middle (residues 12^22) and the C-terminal sections
(residues 23^32). Time averages for the averaged minimum
radii have been computed for each of the sections and are
displayed in Table 1. Simulation of the bundle without any
Fig. 1. Representation of the pentameric bundle of the TM part of
Vpu in the presence of AMþ (light grey, van der Waals representa-
tion) in a side view (upper panel) and view from the C-terminus
into the pore (lower panel) (A). The peptide bundles are shown as
ribbons (black). Tryptophans and serines are highlighted as sticks
(grey scale is used). Lipid and water molecules are omitted for
clarity. HMAþ (light grey) is shown in the same way (B).
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blocker reveals a minimum pore radius of 0.12P 0.06 nm for
the C-terminal section. The simulation with AMþ shows an
opening of the bundle, with an average radius of 0.21P 0.05
nm. The same calculation, taking into account the presence of
the blocker and the consequent obstruction of the pore result-
ing from it, allows computation of the apparent pore radius
and reveals a slightly smaller radius of 0.20 P 0.06 nm. HMAþ
also induces a larger pore radius at this section of the bundle
with values of 0.19 P 0.06 nm (and for the apparent pore rad-
ii : 0.18P 0.06 nm). The middle section remains almost unaf-
fected by the blockers. Average radii of 0.18 P 0.02 nm (AMþ)
and 0.17P 0.03 nm (HMAþ) are close to the value for the
bundle without any blocker at 0.18P 0.03 nm. However, the
presence of the blockers decreases the calculation of the ap-
parent radii to 0.14 P 0.05 nm (for AMþ) and 0.06P 0.04 nm
(for HMAþ). The pore radius in the presence of HMAþ
would not even allow for a single-¢le water passage as found
in gramicidin A [16,17]. Thus, HMAþ completely blocks the
pore. At the N-terminal section, an average pore radius of
0.11P 0.04 nm is calculated without the presence of the block-
er in the pore. The presence of AMþ is accompanied by a
widening of up to 0.17 P 0.04 nm for the N-terminal section.
In the presence of HMAþ the pore narrows (0.13 P 0.05 nm)
compared to the simulations with an empty bundle.
Simulations with the blockers in a neutral state were also
performed. Although this state is unlikely to happen in na-
ture, it allows us to gain more insight into the blocker^protein
interactions by performing ‘impossible’ virtual experiments.
Removing the electrical charge on the guanidinium group
(deprotonated blockers) leads to an overall narrowing of the
pore radii in all three sections (Table 1). The decrease of the
pore opening is more pronounced for the simulations with
AM, particularly in the middle section with a radius of
0.14P 0.03 nm. For HMA, there is a widening of the pore
radius in the middle section (0.06P 0.04 nm C-terminal sec-
tion, 0.16P 0.04 nm middle section, 0.09 P 0.04 nm N-terminal
section). In the middle section the apparent radii decrease to
0.08P 0.03 nm and 0.07P 0.03 nm for AM and HMA, respec-
tively. The two deprotonated blockers result in a blocking of
the C-terminal part with almost identical apparent radii of
V0.05 nm.
To summarise the results, AMþ and to a lesser extent
HMAþ lead to a widening of both the C- and N-terminal
sections. In the presence of HMAþ, the diameter of the N-ter-
minal section is reduced compared to the simulations of the
Vpu bundle in the presence of AMþ. HMAþ induces a ‘fun-
nel’-like shape in the pore, in addition to an almost complete
obstruction of the middle section of the pore. Simulating the
unrealistic situation, where charges on the blockers are re-
moved, leads to an overall narrowing of the pore. The block-
ing resulting from the presence of HMA seems to occur
mainly by occlusion of the pore. These changes, although
relatively small, are found to be signi¢cant at a con¢dence
level of 99.99%.
Water molecules are found only within the pore at the
C-terminal end approaching the blockers during the entire
length of the simulations. Towards the N-terminal end, for
which the pore is lined by highly hydrophobic residues, no
water molecules can be detected. The water molecules, which
are present when each of the models is built, escape from the
pore during the 300-ps equilibration step and do not re-enter
the pore during the simulation.
3.2. The blocker
The RMSD values for AM and AMþ (data not shown) do
not exceed 0.15 nm within the duration of the simulation. The
RMSD values for HMA and HMAþ remain around 0.15 nm,
with a larger £uctuation for the latter (0.1 nm6RMSD6 0.2
nm). The larger values and spread are due to the £exible
hexamethylene ring of the AM derivative. These values are
Fig. 2. RMSD of the CK traces for the pentameric bundle without
blocker (black line), and in the presence of protonated (diamonds)
and deprotonated (circles) blockers. Am (A) and Hma (B).
Table 1
Averaged minimum pore radii of the pentameric bundle when divid-
ed into three sections: the C-terminal (C), middle (M) and N-termi-
nal (N) sections
C (nm) M (nm) N (nm)
Vpu 0.12P 0.06 0.18P 0.03 0.11P 0.04
Bundle (+AMþ) 0.21P 0.05 0.18P 0.02 0.17P 0.04
Bundle+AMþ 0.20P 0.06 0.14P 0.05 0.17P 0.04
Bundle (+HMAþ) 0.19P 0.06 0.17P 0.03 0.13P 0.05
Bundle+HMAþ 0.18P 0.06 0.06P 0.04 0.13P 0.06
Bundle (+AM) 0.05P 0.03 0.14P 0.03 0.09P 0.03
Bundle+AM 0.05P 0.03 0.08P 0.03 0.09P 0.03
Bundle (+HMA) 0.06P 0.04 0.16P 0.04 0.09P 0.04
Bundle+HMA 0.05P 0.04 0.07P 0.03 0.08P 0.04
Each segment is of equal length (approximately 12 amino acids).
Minimum pore radii were averaged over the entire length of each
simulation. The apparent radii are calculated with (e.g.
bundle+HMAþ) and without (e.g. bundle (+HMAþ)) considering
the blockers in the pore.
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within the range of values obtained for Kþ channel blocker
toxins simulated in aqueous solution [18]. In addition, the
RMSFs of the individual atoms of the blockers support this
result. The central bodies of Am (a 3,4,6-substituted pyrazine
ring) and Hma remain fairly rigid (RMSF6 0.1 nm) indepen-
dent of the protonation state of the blockers. Only the hydro-
gen atoms of the amino groups of the pyrazine ring show an
RMSF slightly above 0.1 nm. For both blockers the hydrogen
atoms of the guanidinium group show the largest RMSF
(s 0.1 nm). Overall, the curves are very similar for both
blockers when compared to similar atoms with lower values
for all atoms in the protonated blocker. The atoms of the
hexamethylene ring in Hma are seen to £uctuate around
0.1 nm. The protonation state does not a¡ect the £uctuation
of this part of the molecule.
The di¡erent conformations generated during the MDs for
all four blockers tested were clustered using a full linkage
algorithm, with a cut-o¡ of 0.03 nm for Am and 0.04 nm
for Hma. In the case of AM, this means that molecules
with an RMSD smaller than 0.03 nm relative to all the exist-
ing members of a cluster will belong to this cluster. Cluster
analysis reveals the most populated conformation for each of
the blockers (Fig. 3). AMþ (Fig. 3A) and AM (Fig. 3B) spend
96.0% and 87.9%, respectively, of their time in this conforma-
tion. For HMAþ (Fig. 3C) and HMA (Fig. 3D) the values are
95.1% and 91.5%, respectively. For the protonated blockers,
the carbonyl group linked to the guanidinium group points
towards the primary amine group of the pyrazine ring. De-
protonation of the blockers reveals a conformational change
in the blocker so that the amine part of the guanidinium
group now points to the primary amine group of the pyrazine
ring.
The AMþ forms on average 1.3 hydrogen bonds with water
molecules during the simulation. The threshold for hydrogen
bonding was A^H6 2.5 AU and an angle A^H^D6 60‡, with A
de¢ning the acceptor, D the donor. The number of hydrogen
bonds indicates that, on average, more than one hydrogen
bond is formed between the blocker and the solvent. About
0.82 hydrogen bonds are formed with the side chains of the
serine residues and about 0.19 hydrogen bonds with the back-
bone of the peptide. Barely any hydrogen bonds are formed
with the tryptophan side chains. For AM, the total number of
hydrogen bonds is reduced in the following order: serine side
chain (0.42), solvent (0.14), almost no interactions with the
backbone (0.08) and tryptophans (0.00). For HMAþ, the
water molecules are also the most frequent hydrogen bond
contacts with the blocker (1.7), followed by hydrogen bonding
to the serine side chains (0.77) and tryptophan (0.26). Tryp-
tophans are no longer signi¢cantly involved in hydrogen
bonding with HMA (0.02). As a result, AMþ interacts mainly
with the serine side chains, whilst HMAþ also interacts with
the tryptophans.
Am remains with its long axis almost parallel to the mem-
brane plane independent of its protonation state: 5.3 P 23.3‡
protonated, 8.6 P 51.8‡ deprotonated. The large standard de-
viation is due to the frequent reorientation of the blocker.
Rotational motion around the membrane normal (z-axis), in
the plane of the membrane (x-y plane), is indicated by oscil-
lations in the range of P 40‡ for AMþ. Hma, however, is more
likely to orientate itself out of the membrane plane towards
the membrane normal: 43.0P 11.8‡ protonated, 11.3P 12.7‡
deprotonated. The hexamethylene ring also orientates itself
towards the hydrophobic N-terminal end of the bundle. The
lower standard deviation is indicative of a relatively narrow
band of possible orientations held for a relatively long time
during the simulations. HMAþ screens for the hydrophobic
area of the pore with its hydrophobic methylene ring. Rota-
tion around the membrane normal is restricted to slight £uc-
tuations around 315‡ for HMAþ.
4. Discussion
In a recent publication [4] the blocking of both full-length
Vpu and a peptide corresponding to the TM segment of Vpu
reconstituted into lipid membranes by Am derivatives has
been demonstrated. Also the viral ion channel p7 from hep-
atitis C virus can be blocked by the Am derivative, Hma [19].
With the present investigations we aim to shed light on the
mechanism of interaction between these blockers and a Vpu
bundle. The computational model of the bundle is based on
the available structural and functional information in the lit-
erature (for an overview see [5,6]).
4.1. Plausibility of the bundle model
There is computational and experimental evidence which
supports a model where Vpu adopts a pentameric oligomer-
isation state. Early computational studies based on the TM
part of Vpu were performed with constrained pentameric and
hexameric bundles [20]. The potential energy pro¢les of the
interactions of a cation and an anion with the pore are in
favour of the cation for the pentameric bundle, which sup-
ports the idea of a pentameric oligomerisation state of the
bundle. In an experimentally driven approach using Fourier
transform infrared (FTIR) spectroscopy, a pentameric bundle
showed the lowest potential energy pro¢le and matched most
closely the experimentally derived data, such as the tilt angle
of the peptide inserted into lipid membranes [21]. Comparison
of conductance data with model calculations excludes a tetra-
meric assembly and supports the pentameric model [15]. Fur-
thermore, recent MD simulations show instabilities of hexa-
meric bundles of Vpu compared to pentameric bundles, which
is interpreted as another indication of the pentameric model
as the working model [22].
The consideration of how to build bundles of Vpu has been
discussed previously in detail elsewhere [9]. In brief, the ser-
Fig. 3. Most frequently occupied conformations of Am (A: proton-
ated, B: deprotonated) and Hma (C: protonated, D: deprotonated).
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ines point into the pore which moves the tryptophans to the
outside of the bundle. The orientation of hydrophilic residues,
such as serines, towards the pore is also established for the
nicotinic acetylcholine receptor [23,24]. The consequent posi-
tion of the tryptophans in the bundle model of Vpu has its
experimental veri¢cation in the fact that helical membrane
proteins, such as bacteriorhodopsin [25,26], as well as L-barrel
pores, such as porins [27], have these amino acids anchoring
the protein within the membrane. The macroscopic analysis of
the computational bundles, such as the average tilt angles of
the bundle, falls within the range found experimentally (for an
overview see [6]). The average tilt angle for the bundle without
blocker (5.8 P 2.7‡) seems to be lower than the most recent
experimentally derived value of 13‡ from nuclear magnetic
resonance spectroscopy [28] and closer to the value derived
from FTIR spectroscopy (6.5 P 1.6‡) [21]. The di¡erences may
arise from the use of TM segments which di¡er in length. The
di¡erent lipids used in the individual approaches and the con-
sequent phase conditions they impose may also account for
the di¡erences. The kink angle calculated from the present
bundle structure, taking the CK atoms of the residues Ile-16
to Ala-18 as centre points, is slightly lower compared to the
experimentally derived values [28]. However, calculations of
the kink angle for the extended model Vpu152 as a single
entity in the lipid bilayer [29] ¢t well with the experimentally
derived data [28]. In the current model, the arginine residues
point into the pore in such a way as to compensate the selec-
tivity for cations. However, the arginine side chain is very
£exible and is able to occupy a large conformational space
by swinging in and out of the pore. In a kinked model, the
arginine shows large movements during the simulations [29].
This £exibility might have an impact on the electrostatic pro-
¢le of the C-terminal mouth of the channel and its ion selec-
tivity. As a consequence anions could pass without being
trapped by the positive charges. Glutamate and lysine, the
other charged residues present at the C-terminal end, are posi-
tioned at the outside of the bundle and are proposed to be
involved in clamping of the bundle [6]. The clamp might be
weak and permit a dynamic behaviour of the bundle on a
biologically relevant time scale. These dynamics could also
allow the £ux of larger ions, such as phosphate ions, through
the pore [30].
Consequently, the present model is a reasonably good mod-
el for the simulations on a Vpu bundle.
The missing water molecules within the pore towards the N-
terminal end re£ect the strong hydrophobic character of this
part of the TM segment combined with the small pore radius.
Earlier calculations using cut-o¡ radii for the treatment of
electrostatic interactions revealed continuous water columns
within the pentameric bundle [15]. Recent investigations of
theoretical hydrophobic pore models using PME calculations
show that the presence of water in these pores is strongly
dependent on the pore radius and on membrane polarisation
e¡ects [31^33]. In addition the Lennard^Jones parameters of
the water molecules [34] and the hydrophobic/hydrophilic
character of the walls with which the waters can interact a¡ect
the presence of water molecules [35]. Regarding the pore ra-
dius, below a certain threshold diameter water molecules
would not pass through a pore [31,33]. With increasing pore
size, water will eventually pass in an intermittent way [31,32]
or ‘avalanche-like fashion’ [33]. Simulations on longer time
scales are needed to assess the proper behaviour of the water
molecules in con¢ned geometries. A protein model from the
mechanosensitive channel MscS, with a narrow hydrophobic
part (hydrophobic lock) within the pore similar to Vpu, also
shows the escape or ‘dewetting’ of this part of the pore [36].
The Vpu bundle model used might represent a proper bundle
with a temporary state of low water content. It is possible that
the hydrophobic part contributes to the low conductance
found for the peptide corresponding to the TM segment of
Vpu and reconstituted into lipid membranes [28,30].
4.2. Plausibility of the blocker^protein binding site
Am is a molecule with a considerable number of hydrogen
bond donor groups (amino functions) capable of forming hy-
drogen bonds with hydrogen bond acceptors, such as the ser-
ines. Consequently the C-terminal end of the Vpu bundle with
the serines as putative hydrogen bond acceptors should be a
plausible binding site. In addition, the tryptophans, in an
equilibrated bundle model located at the helix/lipid interface,
may also act as hydrogen bond acceptors. Glu-28, which is
located at the outside of the bundle and could be a hydrogen
bond acceptor, has been found not to interact with either
blocker in a pure docking approach (C. Kim, V. Lemaitre,
A. Watts and W.B. Fischer, to be published). The positive
charge of Arg-30 points into the pore (at pH 7) and seems
to have only the chloride atom and the carbonyl oxygen atom
of the blockers as putative electrostatic counterparts.
With respect to the Am body, the same conclusion applies
for Hma. The hydrophobic ring adds an amphipathic charac-
ter to the blocker. This hydrophobic part is involved in hydro-
phobic interactions with hydrophobic residues of the bundle
within the pore towards the N-terminal end. It should be
noted that molecules containing several methyl groups have
been found to block voltage-gated sodium channels from frog
nerve axons independent of the overall size of the blockers
[37]. This suggests that molecules carrying methyl groups, or
Hma with its hexamethylene ring share a common blocking
mechanism.
4.3. Experimentally and computationally derived evidence for a
binding site and binding geometry of amiloride and other
blockers in ion channels
Hydrophobic interactions with parts of the channel adja-
cent to the AM binding site have been found to increase the
binding a⁄nity of the blocker [38]. For Am, a putative bind-
ing site in the Naþ channel has been proposed to be approx-
imately 20% within the transmembrane electrical ¢eld [39,40]
on the extracellular side [41]. The orientation allows the gua-
nidinium group to penetrate into the pore (reviewed in [42]).
A point mutation within the TM region replacing a crucial
serine residue also abolishes a⁄nity for Am [43]. Conse-
quently, the binding site proposed, with the guanidinium
group in the vicinity of the serines of the putative pore of
Vpu in the present study, is in agreement with ¢ndings on
the epithelial sodium channel.
4.4. E¡ect of hydrogen bonding
The protonated blockers are the physiologically relevant
forms in aqueous solution. The positive charge on the block-
ers was removed in this study to evaluate the role of charge in
the blocking mechanism. The trend of the data for the depro-
tonated blockers parallels the data of the protonated blockers
with respect to their e¡ect on the protein. Comparison of the
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blocker data shows di¡erences in conformation, a larger £uc-
tuation of the guanidinium group and less hydrogen bonding
for the deprotonated blockers. Deprotonation of the blocker
results in a loss of hydrogen bond formation with the side
chains serines and tryptophan, the backbone and water.
HMAþ forms hydrogen bonds with tryptophan, with the
consequence that this residue is moved towards the blocker
into the helix^helix interface and almost into the pore (Fig.
1B). AMþ and also AM form fewer hydrogen bonds on aver-
age suggesting a weaker interaction with the bundle. Hydro-
gen bonding and electrostatic interactions play a major role in
the structural conformation of helical TM proteins/peptides in
the vicinity of hydrophobic areas and also within them
[44,45]. The low dielectric slab of a bilayer imposes a driving
force to saturate any free hydrogen bond with a proton ac-
ceptor [46]. The locations of the guanidinium groups of the
blockers and the serines are at the hydrophilic (headgroup
region)/hydrophobic (hydrophobic slab of the bilayer) inter-
face of the peptide bundle. Consequently the guanidinium
group might anchor the blocker at this particular position.
4.5. Mode of action
The averaged radius of the pore depends on the presence of
the blockers and in particular of HMAþ. A pronounced nar-
rowing of the apparent aperture of the middle of the bundle is
observed when HMAþ is in the pore. For AMþ, the reduction
in pore diameter is less and would therefore allow waters, and
possibly ions with them, to pass the pore along an electro-
chemical gradient. The proposed mechanism of HMAþ block-
ing might also involve interaction with the tryptophans. The
increase in the tilt angle of the bundles in the presence of
AMþ and HMAþ can be best explained by considering the
helices as sliding along each other. This mechanistic view is
supported by the observed increase in the cross angle.
In this study the situation is presented when the blocker has
already reached its binding site. In our current bundle model,
arginine side chains point approximately into the pore. Being
at the entrance of the pore, the side chains are £exible and free
to change their orientation, whilst the backbone is embedded
within a helical environment. On the in vivo time scale these
side chains may £uctuate, allowing the blocker to reach its
binding site. Like other titratable residues, if close to each
other [47], all arginines might not be simultaneously proton-
ated. Temporary deprotonation of one arginine would allow
for an attraction of the guanidinium group towards the argi-
nines and the mouth of the pore. This attraction would lead
to the embedding of the blocker in the pore as outlined.
5. Conclusions
The hydrophilic residue Ser-23 is a favourable binding site
of the blockers. The mode of blocking of HMAþ, once it is in
the pore, is that of steric hindrance. This steric hindrance is
supported by a combination of factors such as hydrogen bond
formation with tryptophan and implementation of slightly
altered pore geometry. AMþ, although favouring the site
within the bundle, is still able to allow for space for water
molecules and ions to pass through. Regarding the pore radi-
us, its impact on the pore is e¡ectively opposite that of the
derivative.
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